Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model - Summary - MDSpire

Determinants of Influenza Vaccine Reluctance in Cancer Patients: A Multicenter Cross-Sectional Analysis Utilizing the Health Belief Model

  • By

  • Qinghua Dong

  • Yiwei Luo

  • Xiaoyu Tang

  • Minye Li

  • Dianjie Chen

  • Zhengji He

  • Qun Xiao

  • Chen Zhi

  • Min Zhu

  • Hui Ma

  • January 24, 2026

  • 0 min

Share

Objective:

To systematically investigate influenza vaccination status and identify predictive factors influencing vaccine hesitancy among cancer patients in China using the Health Belief Model, focusing on specific factors such as perceived susceptibility and barriers.

Key Findings:
  • Cancer patients have a significantly higher vaccine hesitancy rate (42.06%) compared to the general population (35.5%), indicating a critical need for targeted interventions.
  • Vaccination rates among cancer patients are notably lower than those with other chronic conditions, highlighting disparities in health management.
  • The Health Belief Model effectively identifies factors influencing vaccine hesitancy in this population, providing a framework for future interventions.
Interpretation:

The study highlights a critical gap in influenza vaccination among cancer patients, emphasizing the need for targeted interventions to address vaccine hesitancy.

Limitations:
  • The study's reliance on self-reported data may introduce bias, potentially affecting the accuracy of vaccine hesitancy rates.
  • The convenience sampling method may limit the generalizability of the findings, as it may not represent the broader cancer patient population.
Conclusion:

Addressing vaccine hesitancy in cancer patients is essential for improving vaccination rates and health outcomes in this high-risk group, which is crucial for public health initiatives.

Original Source(s)

Related Content